First Time Loading...
S

Second Sight Medical Products Inc
NASDAQ:EYES

Watchlist Manager
Second Sight Medical Products Inc
NASDAQ:EYES
Watchlist
Price: 4.14 USD -5.05%
Updated: May 6, 2024
Section:
 

Relative Value

EYES price has not been updated for more than 5 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of EYES.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

EYES Relative Value
Base Case
Not Available
S
Worst Case
Base Case
Best Case

Valuation Multiples

N/A
P/S
P/S
Price to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-18.3
Median 5Y
-19
Industry
23.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-17.8
Median 5Y
-29.5
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-17.5
Median 5Y
-29
Industry
23.2
More Details
4.3
P/B
P/B
Price to Book Value
4.3
vs History
vs Industry
Median 3Y
2.4
Median 5Y
0
Industry
2.3
More Details
N/A
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.5
More Details
962.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
962.2
vs History
vs Industry
Median 3Y
962.2
Median 5Y
903.3
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-17.5
Median 5Y
-19.3
Industry
12.6
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-17.3
Median 5Y
-19.2
Industry
17.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-16.6
Median 5Y
-29.5
Industry
15.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-16.6
Median 5Y
-29.4
Industry
19.8
More Details
21.7
EV/IC
EV/IC
Enterprise Value to IC
21.7
vs History
vs Industry
Median 3Y
212.7
Median 5Y
25.7
Industry
2
More Details

Multiples Across Competitors

EYES Competitors Multiples
Second Sight Medical Products Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Second Sight Medical Products Inc
NASDAQ:EYES
163.2m USD 0 -18.3 -14.6 -14
US
Abbott Laboratories
NYSE:ABT
183.3B USD 4.5 32.5 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.3B USD 18.5 68.2 55.9 70
US
Stryker Corp
NYSE:SYK
124.2B USD 5.9 36.9 24 29.6
IE
Medtronic PLC
NYSE:MDT
108.5B USD 3.4 25.8 13.7 19.4
US
Boston Scientific Corp
NYSE:BSX
107B USD 7.3 60.5 30.9 45.6
US
Becton Dickinson and Co
NYSE:BDX
68.6B USD 3.5 56 18.8 39.7
DE
Siemens Healthineers AG
XETRA:SHL
58.6B EUR 2.7 38.6 18.5 31.3
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
378.7B CNY 11 33.4 29.1 29.1
US
Edwards Lifesciences Corp
NYSE:EW
51.3B USD 8.4 36.3 26.3 28.5
US
Dexcom Inc
NASDAQ:DXCM
51.3B USD 13.5 80.5 59.9 78

See Also

Summary
EYES intrinsic value, competitors valuation, and company profile.
DCF Valuation
EYES stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EYES stock valuation using valuation multiples.
Wall Street Estimates
EYES price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EYES stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.